BridgeMD
New treatment option for Chronic Migraine
Official title Acceptance and Commitment Therapy to Improve Disability in Chronic Migraine
ClinicalTrials.gov ID: NCT06795867
What this study is testing
- What it's testing
- The goal of this clinical trial is to learn if the behavioral treatment called Acceptance and Commitment Therapy (ACT) works to improve disability in adults with chronic migraine. The main questions it aims to answer are: Does the use of ACT added to usual treatment improve scores on questionnaires designed to measure daily functioning and activity?
- Time commitment: about 2 months
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Willingness and ability to engage in the consent process
- Willingness to participate in the study, despite randomization outcome
- Availability for the duration of the study
- Diagnosis of chronic migraine followed at the Graham Headache Center
- Access to the necessary resources for participating in a technology-based intervention
You likely can't join if
- Known major depression or other psychiatric condition
- Non-English speaking
- Secondary headache diagnosis
- Psychotherapy in the prior 18 months
- Any reason the provider feels would limit participant ability to learn or practice ACT
- Any previous experience with mindfulness or meditation approaches
The study team makes the final eligibility decision.
Where it's taking place
- Boston, Massachusetts, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 2 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Boston, Massachusetts, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.